PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 26 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,244,214 | +3.9% | 246,379 | +3.5% | 0.00% | – |
Q2 2023 | $1,197,890 | +285.2% | 238,149 | +371.0% | 0.00% | – |
Q1 2023 | $310,962 | -52.2% | 50,563 | +2.5% | 0.00% | – |
Q4 2022 | $651,169 | +378.8% | 49,331 | +7.8% | 0.00% | – |
Q3 2022 | $136,000 | -8.1% | 45,754 | +12.9% | 0.00% | – |
Q2 2022 | $148,000 | -42.9% | 40,514 | -3.1% | 0.00% | – |
Q1 2022 | $259,000 | -23.6% | 41,820 | 0.0% | 0.00% | – |
Q4 2021 | $339,000 | -42.2% | 41,820 | +6.3% | 0.00% | – |
Q3 2021 | $586,000 | +28.8% | 39,354 | +8.4% | 0.00% | – |
Q2 2021 | $455,000 | +175.8% | 36,293 | 0.0% | 0.00% | – |
Q1 2021 | $165,000 | +60.2% | 36,293 | -25.0% | 0.00% | – |
Q4 2020 | $103,000 | +243.3% | 48,417 | +276.4% | 0.00% | – |
Q3 2020 | $30,000 | +15.4% | 12,863 | -0.4% | 0.00% | – |
Q2 2020 | $26,000 | +225.0% | 12,912 | +12.6% | 0.00% | – |
Q1 2020 | $8,000 | – | 11,463 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,499,149 | $18,814,000 | 3.39% |
New Leaf Venture Partners, L.L.C. | 117,242 | $7,975,000 | 2.05% |
Worth Venture Partners, LLC | 348,703 | $4,376,000 | 1.63% |
INSPIRION WEALTH ADVISORS, LLC | 253,262 | $3,178,000 | 0.78% |
EAM Global Investors LLC | 187,900 | $2,358,000 | 0.65% |
EAM Investors, LLC | 279,613 | $3,509,000 | 0.54% |
ACT CAPITAL MANAGEMENT, LLC | 45,000 | $565,000 | 0.29% |
Andesa Financial Management Inc. | 33,310 | $418,000 | 0.13% |
Monashee Investment Management LLC | 80,000 | $1,004,000 | 0.12% |
Sofinnova Investments, Inc. | 142,635 | $1,790,000 | 0.10% |